6:53 AM
 | 
Apr 10, 2019
 |  BC Innovations  |  Distillery Therapeutics

Inhibiting bacterial RelA to enhance isoniazid sensitivity in tuberculosis

DISEASE CATEGORY: Infectious disease

INDICATION: Tuberculosis

Cell culture and mouse studies suggest inhibiting M. tuberculosis RelA could help treat chronic-phase tuberculosis (TB), which is resistant to the generic antimalarial isoniazid. In an M. tuberculosis culture-based model...

Read the full 159 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >